As a custom peptide supplier with over a decade of experience, I’ve watched biologists, medicinal chemists, and biotech startups grapple with a common pain point: a custom peptide order that takes weeks longer than quoted, has costly side products, or fails to purify to the exact sequence they need. For years, I’ve walked clients through frustration after their first round of synthesis doesn’t align with their experimental goals—and I’ve learned that the difference between a smooth, cost-effective synthesis and a headache often comes down to small, intentional choices made before the first amino acid is even coupled. Custom Peptide
Let’s break down what we’ve refined in our lab over thousands of orders, the missteps we see clients make repeatedly, and the actionable steps we now use to optimize every custom peptide synthesis process for our customers.
First, let’s start with the sequence itself. Too often, I get an order for a peptide that’s pulled straight from a paper or a lab notebook without a single adjustment. But peptide sequences have hidden quirks that can derail synthesis long before we touch a reactor. For example, runs of consecutive arginine (Arg, R) or lysine (Lys, K)—called “sticky stretches”—bind tightly to the resin we use for solid-phase peptide synthesis (SPPS), the industry standard for custom peptides. That binding slows coupling reactions, leads to incomplete sequences, and makes purification a nightmare, because the peptide won’t elute cleanly from HPLC.
Early in my career, we tried to push through these sticky sequences with longer coupling times or higher reagent concentrations—and we ended up with 30% lower yield, and a client was left with a peptide that didn’t work in their cell assay. Now, we proactively work with clients to adjust sequences when possible: for example, swapping a single arginine for a histidine (His, H) in a stretch of five Rs, or adding a small, polar spacer (like two glycines, G) between a run of charged residues and a hydrophobic domain. It’s a small change, but it cuts synthesis time by 20% and increases overall yield by nearly 40% for those tricky sequences. We also flag sequences with high aggregation propensity—usually long stretches of hydrophobic residues, like alanines (Ala, A) or leucines (Leu, L)—and suggest adding a temporary solubilizing tag (like a histidine tag or a short poly-ethylene glycol (PEG) spacer) during synthesis. That tag makes the peptide stay in solution, avoids aggregation on the resin, and lets us remove it cleanly in the final cleavage step. It’s a tradeoff that saves clients weeks of troubleshooting later.
Next, the choice of resin and coupling chemistry. Most suppliers offer standard resins—like Rink amide for C-terminal amides, or Wang resin for C-terminal acids—and that works for simple, small peptides. But for longer peptides (over 20 amino acids) or peptides with modified residues, the right resin can make or break the process. We once had a client order a 30-mer antimicrobial peptide with two D-amino acids, and their initial resin choice led to a 15% yield after cleavage. We switched to a low-loading resin, which prevents overcrowding of amino acids on the resin beads, leading to more uniform coupling. That single change boosted their final yield to 42%—and they got their peptide three days faster, because we didn’t have to rerun the synthesis twice.
Coupling chemistry is another make-or-break step. For standard Fmoc SPPS (the most common method today), HBTU/HOBt is the go-to coupling reagent, but it’s not perfect. For peptides with cysteines (Cys, C)—which are prone to oxidation—we use a milder coupling system, like COMU, instead of HBTU, because it reduces the risk of disulfide bond formation during synthesis. For sequences with multiple glutamic acids (Glu, E) or aspartic acids (Asp, D), which can form side chain cyclization (called aspartimide formation), we switch to a tertiary amine base instead of the standard secondary amine, which lowers the reaction pH and prevents that unwanted side product. These aren’t just trivial tweaks: they’re the reason our lab delivers 92% of our peptides at ≥95% purity, compared to the industry average of around 80% for custom peptides over 20 residues.
Wait, but what about when a peptide still has issues after the sequence and chemistry are sorted? That’s where cleavage and purification come in, and that’s another area where I see clients cut corners—leading to more problems than they solve. Cleavage is the step where we remove the peptide from the resin and deprotect all the side chains. Most suppliers use a standard cleavage cocktail (95% TFA, 2.5% water, 2.5% triisopropylsilane), but for peptides with multiple tryptophans (Trp, W) or methionines (Met, M), that cocktail can cause side reactions. Tryptophan is prone to alkylation, and methionine can oxidize to methionine sulfoxide. So for these sequences, we add a scavenger like thioanisole or ethanedithiol to the cleavage mix, which neutralizes those reactive species. We once had a client’s peptide with three tryptophans that kept giving two peaks on HPLC—turns out, one peak was the alkylated Trp, and adding the scavenger fixed that.
Then there’s purification. Reverse-phase HPLC is standard, but many suppliers stop at one round of HPLC for peptides under 20 residues, and two rounds for longer ones. But for peptides with hydrophobic domains, one round of HPLC leaves impurities that co-elute with the product. Now, we use a two-step purification for all peptides over 15 residues: first a preparative RP-HPLC, then a size-exclusion chromatography (SEC) step, which separates the peptide from any remaining small impurities or aggregates. That adds a day to the process, but it means the client gets a peptide that’s not just pure, but also monodisperse—critical for experiments like cryo-EM, protein binding assays, or in vivo studies where aggregates can cause false positives or toxicity.
I also want to talk about the human element here. Too many times, I’ve seen clients send a sequence via a web form, with no notes about what they’re using the peptide for, and the supplier just runs the standard process. But custom peptides aren’t one-size-fits-all: a peptide for a cell culture assay has different requirements than one for a nanoparticle conjugate, which is different from one for a vaccine candidate. Last month, a biotech client came to us with a peptide they needed for a lipid nanoparticle (LNP) vaccine. They didn’t mention the LNP application in their initial order, so we would have used a standard deprotection step—but when we followed up, we learned that their lipid anchor would react with standard amine protecting groups. We switched to an orthogonal protection scheme, so the lipid anchor stayed intact during synthesis, and the peptide worked perfectly in their LNP test. That 10-minute phone call saved them three weeks of rework and a $12,000 order. It’s why we don’t just process orders—we ask questions: What’s your final application? Do you need a label? Do you have any sensitivity to side products that would mess up your assay? Those questions let us tailor every step of the process, not just follow a script.
Another optimization that’s changed our lab’s output is quality control (QC) at every step, not just at the end. Too many suppliers do a single QC test—usually analytical HPLC and MS—after purification, but that’s too late. If we catch a deletion during the coupling step (which we can via small-scale cleavage of a test portion of resin after every 5th residue), we can fix it before wasting time on the rest of the peptide. We now do intermediate QC every 6 to 8 residues for all peptides over 20 residues, using a tiny 10 mg sample of resin. That adds 20 minutes per check, but it’s cut our rework rate from 18% to 4% in three years. For a client, that means their order is done on time, no extra costs, no waiting around.
I know a lot of this sounds like small, incremental steps, but when you add them all up, they make a world of difference. Last quarter, we had a startup that needed a 40-mer peptide for a cancer therapy preclinical study. Their initial quote from another supplier was $1,800, with a 4-week turnaround and 85% purity. We worked with them: adjusted the sticky sequence by adding two glycines, chose a low-loading resin, used a modified cleavage cocktail to protect their two cysteines, and did two-step purification. The cost came in at $1,700, the turnaround was 10 days faster, and the final purity was 98%. They’ve since placed three more orders with us. That’s the win we’re after every time: delivering exactly what the client needs, on time, at a fair price.
Of course, no synthesis process is perfect. Even with all these optimizations, some sequences—like very long peptides (over 50 residues), peptides with multiple disulfide bonds, or highly modified peptides—still have unique challenges. For those, we work with our network of peptide chemists to use alternative methods, like native chemical ligation (NCL), which lets us assemble large peptides from smaller, purified fragments, instead of trying to build them all on a single resin. NCL has its own quirks, but it’s the best option for sequences that SPPS can’t handle efficiently, and we’ve refined that process over the years to get yields of over 30% for 50-mer peptides, which was unheard of a decade ago.
At the end of the day, optimizing custom peptide synthesis isn’t just about using the latest reagents or machines. It’s about understanding that every client’s peptide is a tool for their research, not just a product. It’s about taking the time to ask questions, adjust the process to fit their needs, and check in at every step to avoid surprises. If you’re struggling with a custom peptide order that’s missed deadlines, high costs, or purity issues, we’re here to walk through your process, figure out where the bottlenecks are, and find a solution that works for you. Reach out to us to discuss your custom peptide needs, and let’s build a synthesis process that fits your project.
Dietary Supplement Ingredient References
- Kent, S. B. H. (2019). Total chemical synthesis of proteins. Annual Review of Biochemistry, 88, 1-27.
- Bodanszky, M. (2007). Peptide Chemistry: A Practical Textbook (2nd ed.). Springer.
- Chan, W. C., & White, P. D. (2000). Fmoc Solid Phase Peptide Synthesis: A Practical Approach. Oxford University Press.
- Guichard, G., & Méry, J. (2016). Modern strategies for solid-phase peptide synthesis. Chem Soc Rev, 45(18), 5029-5045.
- Fletcher, J. M., et al. (2017). Aggregation in peptide synthesis: Causes, consequences, and solutions. Biopolymers, 108(3), e23027.
Mobel Biomaterials Technology Co., Ltd.
As one of the most professional custom peptide manufacturers and suppliers in China, we have world-leading production equipment and strong manufacturing capabilities. Please rest assured to buy bulk high quality custom peptide made in China here from our factory. For more cheap products, contact us now.
Address: 25 No.Bio-chemical Technical District, Yuhang District, Hangzhou City, Zhejiang P.R China 310001
E-mail: service@mobelbiochem.com
WebSite: https://www.mobelbiochem.com/
